Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications.
Quinn CM, Rajarajan P, Gill AJ, Kopinsky H, Wolf AB, de Camargo CS, Lamb J, Bacon TE, Murray JC, Probasco JC, Galetta KM, Kantor D, Coyle P, Bhise V, Alvarez E, Conway SE, Bhattacharyya S, Kister I.
Quinn CM, et al. Among authors: conway se.
Neurology. 2024 Dec 10;103(11):e210003. doi: 10.1212/WNL.0000000000210003. Epub 2024 Nov 14.
Neurology. 2024.
PMID: 39541548